Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded access program.

Columnist Ben Hofmeister explains how songs such as "No One Is to Blame" have become part of the soundtrack of his life with MS.

Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less ...

Switching from CD20 inhibitors to fumarate therapies reduces healthcare visits and infection-related costs, while controlling ...

A low educational status was associated with longer delays before initiating treatment among relapsing-remitting MS patients ...

TG Therapeutics will use MaxCyte’s technology to advance toward a clinical trial its azer-cel CAR T-cell therapy for ...

Stress management strategies such as mindfulness and exercise can help you manage your multiple sclerosis (MS) diagnosis.

Multiple sclerosis home adaptations that include adaptive equipment and technology can help prevent falls for people living ...

The study estimated annual mortality rates for 5,797 individuals with MS compared with 28,807 controls with a similar age, ...

When managing a complex chronic condition like multiple sclerosis, having good communication and trust with your doctor is ...

Scientists interviewed 17 patients who reported feeling unmoored by a disease that has stripped away their sense of control ...

The Floodlight MS app, used to track disease progression in people with multiple sclerosis, has been deemed cost-effective in ...